Journey Medical (DERM) Institutional Ownership $6.78 -0.10 (-1.45%) As of 02:25 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Journey Medical (NASDAQ:DERM)CurrentInstitutional OwnershipPercentage7.25%Number ofInstitutional Buyers(last 12 months)15TotalInstitutional Inflows(last 12 months)$11.03MNumber ofInstitutional Sellers(last 12 months)10TotalInstitutional Outflows(last 12 months)$1.39M Get DERM Insider Trade Alerts Want to know when executives and insiders are buying or selling Journey Medical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data DERM Institutional Buying and Selling by Quarter Journey Medical Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/21/2025Acadian Asset Management LLC4,772$28K0.0%-72.5%0.021% 5/19/2025 Jane Street Group LLC18,599$110K0.0%N/A0.081% 5/16/2025 Integrated Wealth Concepts LLC56,850$335K0.0%-3.4%0.246% 5/15/2025 Titleist Asset Management LLC12,900$76K0.0%+18.3%0.056% 5/14/2025 Pale Fire Capital SE27,274$161K0.0%N/A0.118% 5/13/2025 Kovitz Investment Group Partners LLC21,710$128K0.0%-12.1%0.094% 4/22/2025 Cambridge Investment Research Advisors Inc.338,050$1.99M0.0%+3.0%1.463% 2/17/2025 Tang Capital Management LLC1,725,569$6.75M0.4%N/A8.260% 2/17/2025 Cetera Investment Advisers13,839$54K0.0%+21.8%0.066% 2/17/2025 Citadel Advisors LLC44,568$174K0.0%N/A0.213% Get the Latest News and Ratings for DERM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Journey Medical and its competitors with MarketBeat's FREE daily newsletter. 2/14/2025 Kovitz Investment Group Partners LLC24,710$97K0.0%+112.9%0.118% 2/14/2025 Integrated Wealth Concepts LLC58,850$230K0.0%-4.1%0.282% 2/14/2025 Dimensional Fund Advisors LP20,455$80K0.0%N/A0.098% 2/13/2025 Renaissance Technologies LLC236,000$923K0.0%-12.0%1.130% 2/13/2025 Titleist Asset Management LLC10,900$43K0.0%-23.5%0.052% 2/13/2025 Envestnet Asset Management Inc.103,557$405K0.0%-5.5%0.496% 1/29/2025 Gladstone Institutional Advisory LLC29,981$117K0.0%-10.5%0.144% 11/25/2024PVG Asset Management Corp167,545$947K3.8%+5.7%0.802% 11/16/2024 Geode Capital Management LLC108,435$613K0.0%+13.5%0.523% 11/15/2024 Kovitz Investment Group Partners LLC11,605$66K0.0%N/A0.056% 11/14/2024 Walleye Capital LLC23,098$131K0.0%-63.7%0.111% 11/12/2024 Nwam LLC10,430$59K0.0%N/A0.050% 11/1/2024 Atria Investments Inc44,397$251K0.0%-19.8%0.214% 10/30/2024 Rosalind Advisors Inc.105,917$598K0.4%-7.2%0.529% 10/11/2024 ORG Wealth Partners LLC19,519$110K0.0%N/A0.094% 8/22/2024PVG Asset Management Corp158,540$894K3.5%N/A0.792% 8/9/2024 Renaissance Technologies LLC264,025$1.49M0.0%-2.4%1.319% 8/8/2024TMD Wealth Management LLC11,605$65K0.0%N/A0.058% 8/6/2024Acadian Asset Management LLC94,404$531K0.0%-57.6%0.472% 7/26/2024 Cambridge Investment Research Advisors Inc.294,950$1.66M0.0%N/A1.474% 7/12/2024 Rosalind Advisors Inc.114,132$644K0.5%N/A0.570% 5/14/2024 Heron Bay Capital Management33,669$124K0.0%N/A0.169% 5/10/2024Acadian Asset Management LLC222,663$817K0.0%+687.5%1.117% 5/10/2024 Perkins Capital Management Inc.22,000$81K0.1%-31.3%0.110% 5/10/2024 Nwam LLC11,820$41K0.0%N/A0.059% (Data available from 1/1/2016 forward) DERM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DERM shares? During the previous two years, 24 institutional investors and hedge funds held shares of Journey Medical. The most heavily invested institutionals were Tang Capital Management LLC ($6.75M), Cambridge Investment Research Advisors Inc. ($1.99M), PVG Asset Management Corp ($947K), Renaissance Technologies LLC ($923K), Geode Capital Management LLC ($613K), Rosalind Advisors Inc. ($598K), and Envestnet Asset Management Inc. ($405K).Learn more on DERM's institutional investors. What percentage of Journey Medical stock is owned by institutional investors? 7.25% of Journey Medical stock is owned by institutional investors. Learn more on DERM's institutional investor holdings. Which institutional investors have been buying Journey Medical stock? Of the 17 institutional investors that purchased Journey Medical stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Tang Capital Management LLC ($1.73M), Cambridge Investment Research Advisors Inc. ($304.89K), Acadian Asset Management LLC ($194.39K), PVG Asset Management Corp ($167.55K), Rosalind Advisors Inc. ($114.13K), Citadel Advisors LLC ($44.57K), and Heron Bay Capital Management ($33.67K). How much institutional buying is happening at Journey Medical? Institutional investors have bought a total of 2,746,532 shares in the last 24 months. This purchase volume represents approximately $11.91M in transactions. Which Journey Medical major shareholders have been selling company stock? Of the 11 institutional investors that sold Journey Medical stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Acadian Asset Management LLC ($140.84K), Walleye Capital LLC ($40.48K), Renaissance Technologies LLC ($38.78K), Atria Investments Inc ($10.94K), Perkins Capital Management Inc. ($10K), Rosalind Advisors Inc. ($8.22K), and Envestnet Asset Management Inc. ($6.03K). How much institutional selling is happening at Journey Medical? Institutional investors have sold a total of 269,634 shares in the last 24 months. This volume of shares sold represents approximately $1.42M in transactions. Related Companies Xencor Institutional Ownership AbCellera Biologics Institutional Ownership ChromaDex Institutional Ownership KalVista Pharmaceuticals Institutional Ownership Replimune Group Institutional Ownership Bicycle Therapeutics Institutional Ownership AnaptysBio Institutional Ownership Cogent Biosciences Institutional Ownership Sionna Therapeutics Institutional Ownership Keros Therapeutics Institutional Ownership This page (NASDAQ:DERM) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Journey Medical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Journey Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
